Albrus Biotec India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 251.64%
- Profit Growth 253.15%
- Ebitda 253.26%
- Net Worth 107.16%
- Total Assets 201.30%
About Albrus Biotec India
Albrus Biotec India Private Limited (ABIPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 July 2014 and has a history of Ten years and six months. Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhinav Gour and Santosh Goyal serve as directors at the Company.
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232MP2014PTC032940
-
Company No.
032940
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jul 2014
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Albrus Biotec India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Gour
|
Director | 21-Jul-2014 | Current |
|
Santosh Goyal
|
Director | 20-Jan-2017 | Current |
Financial Performance of Albrus Biotec India.
Albrus Biotec India Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 251.64% increase. The company also saw a substantial improvement in profitability, with a 253.15% increase in profit. The company's net worth Soared by an impressive increase of 107.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Albrus Biotec India?
In 2017, Albrus Biotec India had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Albrus Biotec India?
Unlock and access historical data on people associated with Albrus Biotec India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albrus Biotec India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albrus Biotec India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
